Miami Fat Supply, Inc
Letter data
- Company
- Miami Fat Supply, Inc
- Recipient
- Miami Fat Supply, Inc | United States
- Issue date
- 2018-01-19
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 485740
- Reference number
- Not available
- FEI
- 3008872140
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Miami Fat Supply, Inc
MARCS-CMS 485740 —
January 19, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Miami Fat Supply, Inc
United States
Issuing Office:
United States
Florida District Office
555 Winderley Place #200
Maitland, FL 32751
Telephone:
(407) 475-4700
VIA ELECTRONIC MAIL
mark@miamifatsupply.com
January 19, 2018
Mr. D. Mark Jordan, President
Miami Fat Supply, Inc.
1510 Max Hooks Road, #F
Groveland, Florida 34736 U.S.A.
RE: Warning Letter Close-Out Letter – FEI 3008872140
CMS Case ID: 485740, CMS WA ID: 182270
Dear Mr. Jordan:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter FLA-16-12, dated March 17, 2016. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Kathleen M. Sinninger
Acting Program Division Director
Division of Medical Devices and
Radiological Health Operations II Central
Content current as of:
01/23/2018